The R&D industry has been evolving for decades to make the process of discovering new compounds and formulations in the laboratory easier and more effective. Today, innovative trends, focused predominantly around data and technology, encourage changes that aim to improve efficiencies across the industry. A couple of current trends we’re observing include open innovation (or externalization), as well as big data.
With the help of ACD/Labs’ software, PharmaSea researchers have dereplicated more than 300 extracts, and, as a result, have identified 10 novel compounds that merit further research. Prof. Marcel Jaspars, head of the Marine Biodiscovery Centre at the University of Aberdeen, and project leader of PharmaSea, discusses the PharmaSea project in detail here.
ACD/Labs is headed to Boston for the annual Bio-IT World Conference & Expo held at the Seaport World Trade Center from April 5th-7th. Over 3,000 life sciences, IT, and pharmaceutical professionals will gather in Beantown to discuss the emerging technologies and research that is transforming the industry. As the newest member of the team, rejoining ACD/Labs as Vice President of Business Development in December 2015, I’m ecstatic to be at this year’s conference alongside my colleagues Sanji Bhal, Graham McGibbon and Larry Brescio. Read more to find out what I’ll be up to at the show and where you can find the ACD/Labs team.
This is always an exciting time of year in the NMR community. The early part of the year usually offers a few “quiet moments” to work on projects that have not been receiving enough attention. However, quite quickly we enter into the conference season, with PANIC, PITTCON, ACS, and ENC in short order. These meetings are an excellent opportunity to connect with new science, reconnect with old colleagues, and meet some new faces.
At ACD/Labs, we have spent two decades working with customer organizations to support effective analytical data management. While we are privy to the problems of our customers, we wondered how the wider R&D community has been addressing analytical data management and what challenges remained. With that in mind, we decided to conduct a survey last year to gather feedback from scientists (62% of survey respondents), managers, directors, and executives (26%), as well as IT and other professionals (12%) to better understand the R&D landscape.
Join us at PITTCON 2016 in Atlanta, Georgia, as we participate in a number of presentations, network with our fellow scientists and discuss upcoming mixture analysis capabilities on the ACD/Spectrus Platform.
The 'Amazon Effect' describes how online shopping giant, Amazon, sorts data and matches similar products to one another—providing customers with a customized list of products they may be interested in. In laboratory informatics, scientists organize and analyze data in a very similar way. By using software like ACD/Spectrus Platform, scientists—from different laboratories using a variety of instruments—can combine and process their large data sets in a single interface that delivers quality results.
En route to SLAS 2016 in San Diego to talk about ‘Tackling Obstacles to Analytical Knowledge Externalization’ I was struck by the congruity of the breathtaking road I was taking with the topic planned for the Informatics–Data Wrangling session. National Geographic noted the road as “An exhilarating driving experience…In places, the road has narrow shoulders and sharp drop-offs, so stay alert”. The Informatics landscapes of modern science-based organizations also offer remarkable challenges to navigate.
Over the course of the last four months, we have been working with Scientific Computing to publish a series of articles on a subject that we feel very passionately about (and work very close with) at ACD/Labs – the externalization of scientific research and development (read the summary here). Essentially, we used this opportunity to address some key trends specific to this topic from various perspectives in the industry. Now that the series is complete, I wanted to give you an overview of the four articles to paint a broader picture of what we, and some of our customers and partners, are seeing today.
I speak for our organization when I say the entire ACD/Labs team feels continuously connected to the successes of our customers. Like most of you, members of our team have dedicated years to the advancement of chemistry R&D, which has led to many business relationships, and more importantly, personal friendships. It’s not only our business, it’s our passion. On behalf of all of us at ACD/Labs, I would like to wish you a successful year ahead!